Page last updated: 2024-10-21

3-aminobenzamide and Retinal Degeneration

3-aminobenzamide has been researched along with Retinal Degeneration in 2 studies

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sahaboglu, A1
Miranda, M1
Canjuga, D1
Avci-Adali, M1
Savytska, N1
Secer, E1
Feria-Pliego, JA1
Kayık, G1
Durdagi, S1
Miki, K1
Uehara, N1
Shikata, N1
Matsumura, M1
Tsubura, A1

Other Studies

2 other studies available for 3-aminobenzamide and Retinal Degeneration

ArticleYear
Drug repurposing studies of PARP inhibitors as a new therapy for inherited retinal degeneration.
    Cellular and molecular life sciences : CMLS, 2020, Volume: 77, Issue:11

    Topics: Animals; Benzamides; Drug Repositioning; Humans; Mice; Phthalazines; Poly(ADP-ribose) Polymerase Inh

2020
Poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide rescues N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats through preservation of nuclear factor-kappaB activity.
    Experimental eye research, 2007, Volume: 84, Issue:2

    Topics: Animals; Apoptosis; Benzamides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Methyln

2007